Artivion Announces Financial Results Release Date
Artivion, Inc. (NYSE: AORT), a prominent player in cardiac and vascular surgery solutions, has set a date to unveil its first quarter 2025 financial results. This significant event will occur on an upcoming Monday in May, just after the market closes. Investors and interested parties can look forward to a comprehensive discussion regarding the company’s performance during this period.
Teleconference Call Details
On the chosen date, a teleconference call is slated to be held at 4:30 p.m. ET. This interactive session will provide an avenue for the company to share insights related to its financial performance, operations, and strategic initiatives. Pat Mackin, who serves as the Chairman, President, and Chief Executive Officer of Artivion, will be leading the discussion.
How to Join the Teleconference
Participants interested in listening to the live teleconference should dial 201-689-8261 a few minutes before the start time. For those unable to join live, a replay will be available shortly after the event concludes. This can be accessed by calling either 877-660-6853 or 201-612-7415, with the designated conference number required for the replay being 13752340.
Accessing the Webcast
In addition to the teleconference, Artivion will offer a live webcast accessible on their website's Investors section. This feature enables broader participation, allowing stakeholders to tune in from anywhere. Additionally, the webcast replay will also be available for those who cannot attend the initial presentation.
Financial Insights to be Shared
The forthcoming earnings press release will provide a thorough overview of the financial and statistical performance for the completed quarter as well as the full year. This crucial document will also be accessible in the Investors section of the Artivion website.
About Artivion, Inc.
Headquartered in the heart of the industry, Artivion, Inc. is at the forefront of medical device innovation. They are committed to delivering cutting-edge solutions that tackle the intricate challenges faced by cardiac and vascular surgeons, particularly in the treatment of aortic diseases. Their diverse product portfolio encompasses aortic stent grafts, surgical sealants, On-X mechanical heart valves, and human tissues tailored for cardiac and vascular applications.
Artivion's footprint extends across more than 100 countries, reflecting their commitment to global health. Their innovative approach not only enhances surgical outcomes but also significantly improves the quality of life for patients globally. For further details about the company's offerings, visiting their official website can provide valuable insights.
Contact Information
For media or investor inquiries, please contact:
Artivion, Inc.
Lance A. Berry
Executive Vice President & Chief Financial Officer
Phone: 770-419-3355
Gilmartin Group LLC
Brian Johnston / Laine Morgan
Phone: 332-895-3222
Frequently Asked Questions
What date will Artivion release its financial results?
Artivion's financial results for the first quarter of 2025 will be released on a Monday in May, after market close.
How can I listen to the teleconference?
To join the teleconference, dial 201-689-8261 a few minutes before 4:30 p.m. ET on the scheduled date.
Will there be a replay of the teleconference?
Yes, a replay will be available shortly after the event by calling 877-660-6853 or 201-612-7415 with the conference number 13752340.
What products does Artivion specialize in?
Artivion specializes in medical devices focusing on aortic diseases, including stent grafts, surgical sealants, On-X heart valves, and various human tissues.
Where can I find more information about Artivion?
For more details about Artivion and their products, you can visit their official website.
